http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 05 Aug 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Foundation+for+Angelman+Syndrome+Therapeutics+Announces+Agreement+with+Apertura+Gene+Therapy+for+Access+to+Blood-Brain+Barrier-Crossing+Capsid/26870606.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Foundation+for+Angelman+Syndrome+Therapeutics+Announces+Agreement+with+Apertura+Gene+Therapy+for+Access+to+Blood-Brain+Barrier-Crossing+Capsid/26870606.html for the full story. http://www.streetinsider.com/Press+Releases/Foundation+for+Angelman+Syndrome+Therapeutics+Announces+Agreement+with+Apertura+Gene+Therapy+for+Access+to+Blood-Brain+Barrier-Crossing+Capsid/26870606.html Wed, 05 Aug 2026 08:00:00 -0400 A.04232622 A.50216944 O.14910686 O.65543146 http://www.streetinsider.com/Press+Releases/TSC+Alliance+and+Apertura+Gene+Therapy+Complete+Preclinical+Pilot+Study+Evaluating+AAV+Gene+Therapy+Approach+Designed+for+TSC1/26839206.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/TSC+Alliance+and+Apertura+Gene+Therapy+Complete+Preclinical+Pilot+Study+Evaluating+AAV+Gene+Therapy+Approach+Designed+for+TSC1/26839206.html for the full story. http://www.streetinsider.com/Press+Releases/TSC+Alliance+and+Apertura+Gene+Therapy+Complete+Preclinical+Pilot+Study+Evaluating+AAV+Gene+Therapy+Approach+Designed+for+TSC1/26839206.html Thu, 30 Jul 2026 08:00:00 -0400 A.50216944 O.65543146 http://www.streetinsider.com/Press+Releases/MMI+Receives+FDA+Approval+to+Advance+to+Phase+II+of+Patient+Enrollment+in+Groundbreaking+REMIND+Microsurgical+Study+in+Alzheimer%E2%80%99s+Patients/26839110.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MMI+Receives+FDA+Approval+to+Advance+to+Phase+II+of+Patient+Enrollment+in+Groundbreaking+REMIND+Microsurgical+Study+in+Alzheimer%E2%80%99s+Patients/26839110.html for the full story. http://www.streetinsider.com/Press+Releases/MMI+Receives+FDA+Approval+to+Advance+to+Phase+II+of+Patient+Enrollment+in+Groundbreaking+REMIND+Microsurgical+Study+in+Alzheimer%E2%80%99s+Patients/26839110.html Thu, 30 Jul 2026 08:00:00 -0400 http://www.streetinsider.com/Press+Releases/Apertura+Gene+Therapy+Named+to+Consortium+Receiving+Funding+from+the+Advanced+Research+Projects+Agency+for+Health+%28ARPA-H%29+THRIVE+Program+to+Develop+Gene+Therapies+for+Rare+Childhood+Diseases/26806778.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Apertura+Gene+Therapy+Named+to+Consortium+Receiving+Funding+from+the+Advanced+Research+Projects+Agency+for+Health+%28ARPA-H%29+THRIVE+Program+to+Develop+Gene+Therapies+for+Rare+Childhood+Diseases/26806778.html for the full story. http://www.streetinsider.com/Press+Releases/Apertura+Gene+Therapy+Named+to+Consortium+Receiving+Funding+from+the+Advanced+Research+Projects+Agency+for+Health+%28ARPA-H%29+THRIVE+Program+to+Develop+Gene+Therapies+for+Rare+Childhood+Diseases/26806778.html Thu, 23 Jul 2026 12:00:00 -0400 A.04232622 A.50216944 O.14910686 O.65543146 http://www.streetinsider.com/Press+Releases/Apertura+Gene+Therapy+Announces+Cooperative+Research+and+Development+Agreement+with+Institutes+of+the+NIH+to+Test+Investigational+Gene+Therapy+for+Niemann-Pick+Disease+Type+C1/26750405.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Apertura+Gene+Therapy+Announces+Cooperative+Research+and+Development+Agreement+with+Institutes+of+the+NIH+to+Test+Investigational+Gene+Therapy+for+Niemann-Pick+Disease+Type+C1/26750405.html for the full story. http://www.streetinsider.com/Press+Releases/Apertura+Gene+Therapy+Announces+Cooperative+Research+and+Development+Agreement+with+Institutes+of+the+NIH+to+Test+Investigational+Gene+Therapy+for+Niemann-Pick+Disease+Type+C1/26750405.html Thu, 09 Jul 2026 08:00:00 -0400 A.04232622 A.50216944 O.14910686 O.65543146 http://www.streetinsider.com/Press+Releases/3-Year+DETOUR2+Results+Demonstrate+Sustained+Symptom+Relief+and+Limb+Preservation+in+Complex+SFA+Disease/26724661.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/3-Year+DETOUR2+Results+Demonstrate+Sustained+Symptom+Relief+and+Limb+Preservation+in+Complex+SFA+Disease/26724661.html for the full story. http://www.streetinsider.com/Press+Releases/3-Year+DETOUR2+Results+Demonstrate+Sustained+Symptom+Relief+and+Limb+Preservation+in+Complex+SFA+Disease/26724661.html Thu, 02 Jul 2026 09:00:00 -0400 A.23636062 A.33357082 O.00674125 O.41740509 http://www.streetinsider.com/Corporate+News/METiS+TechBio+licenses+T-cell+engager+to+Boulevard+Bio+for+up+to+%241.6B/26708629.html Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/METiS+TechBio+licenses+T-cell+engager+to+Boulevard+Bio+for+up+to+%241.6B/26708629.html for the full story. http://www.streetinsider.com/Corporate+News/METiS+TechBio+licenses+T-cell+engager+to+Boulevard+Bio+for+up+to+%241.6B/26708629.html Tue, 30 Jun 2026 05:37:53 -0400 7666 A.04232622 O.14910686 http://www.streetinsider.com/Press+Releases/METiS+TechBio+and+Boulevard+Bio+Enter+Global+License+Agreement+for+Trispecific+T-cell+Engager/26708628.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/METiS+TechBio+and+Boulevard+Bio+Enter+Global+License+Agreement+for+Trispecific+T-cell+Engager/26708628.html for the full story. http://www.streetinsider.com/Press+Releases/METiS+TechBio+and+Boulevard+Bio+Enter+Global+License+Agreement+for+Trispecific+T-cell+Engager/26708628.html Tue, 30 Jun 2026 05:37:00 -0400 7666 A.04232622 O.14910686 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26667541.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26667541.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Nuvalent%2C+Inc.++++++++++++For%3A+Jun+16++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26667541.html Thu, 18 Jun 2026 18:35:00 -0400 NUVL O.51068808 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Parabilis+Medicines%2C++++++For%3A+Jun+11++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26637225.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Parabilis+Medicines%2C++++++For%3A+Jun+11++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26637225.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Parabilis+Medicines%2C++++++For%3A+Jun+11++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26637225.html Thu, 11 Jun 2026 20:08:00 -0400 PBLS http://www.streetinsider.com/Press+Releases/Deerfield+Management+Announces+Portfolio+Company+Nuvalent%2C+Inc.+to+be+Acquired+by+GSK/26628828.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Deerfield+Management+Announces+Portfolio+Company+Nuvalent%2C+Inc.+to+be+Acquired+by+GSK/26628828.html for the full story. http://www.streetinsider.com/Press+Releases/Deerfield+Management+Announces+Portfolio+Company+Nuvalent%2C+Inc.+to+be+Acquired+by+GSK/26628828.html Wed, 10 Jun 2026 12:20:00 -0400 A.04232622 A.07880129 O.14910686 O.21200813 http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Parabilis+Medicines%2C++++++For%3A+Jun+09++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26625339.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Parabilis+Medicines%2C++++++For%3A+Jun+09++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26625339.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++3++++++++++Parabilis+Medicines%2C++++++For%3A+Jun+09++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26625339.html Tue, 09 Jun 2026 21:15:00 -0400 http://www.streetinsider.com/Press+Releases/Stelexis+BioSciences+Announces+Positive+Phase+1+Data+for+Eganelisib+in+RelapsedRefractory+AML+and+Higher-Risk+MDS+in+an+Oral+Presentation+at+ASCO+2026/26589354.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Stelexis+BioSciences+Announces+Positive+Phase+1+Data+for+Eganelisib+in+RelapsedRefractory+AML+and+Higher-Risk+MDS+in+an+Oral+Presentation+at+ASCO+2026/26589354.html for the full story. http://www.streetinsider.com/Press+Releases/Stelexis+BioSciences+Announces+Positive+Phase+1+Data+for+Eganelisib+in+RelapsedRefractory+AML+and+Higher-Risk+MDS+in+an+Oral+Presentation+at+ASCO+2026/26589354.html Tue, 02 Jun 2026 10:23:00 -0400 A.04232622 A.50209015 O.00225875 O.14910686 http://www.streetinsider.com/Press+Releases/MMI+Earns+Gold+Edison+Award+for+Symani%C2%AE%2C+Recognized+for+Expanding+Access+to+Life-Changing+Surgical+Treatment+Options/26562563.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/MMI+Earns+Gold+Edison+Award+for+Symani%C2%AE%2C+Recognized+for+Expanding+Access+to+Life-Changing+Surgical+Treatment+Options/26562563.html for the full story. http://www.streetinsider.com/Press+Releases/MMI+Earns+Gold+Edison+Award+for+Symani%C2%AE%2C+Recognized+for+Expanding+Access+to+Life-Changing+Surgical+Treatment+Options/26562563.html Thu, 28 May 2026 09:30:00 -0400 http://www.streetinsider.com/Press+Releases/Adela+Highlights+Progress+on+Multi-Cancer+Early+Detection+Study+at+the+2026+ASCO+Annual+Meeting/26546808.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Adela+Highlights+Progress+on+Multi-Cancer+Early+Detection+Study+at+the+2026+ASCO+Annual+Meeting/26546808.html for the full story. http://www.streetinsider.com/Press+Releases/Adela+Highlights+Progress+on+Multi-Cancer+Early+Detection+Study+at+the+2026+ASCO+Annual+Meeting/26546808.html Tue, 26 May 2026 09:00:00 -0400 A.01718595 A.04232622 A.11607473 O.00173827 O.00786770 O.14910686 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Larimar+Therapeutics%2C+++++For%3A+May+19++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26529969.html Visit StreetInsider.com at http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Larimar+Therapeutics%2C+++++For%3A+May+19++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26529969.html for the full story. http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Larimar+Therapeutics%2C+++++For%3A+May+19++Filed+by%3A+DEERFIELD+MANAGEMENT+COMPANY%2C+L.P./26529969.html Wed, 20 May 2026 20:03:00 -0400 LRMR O.08621740 http://www.streetinsider.com/Press+Releases/Endologix+Acquires+Pounce%E2%84%A2+Thrombectomy+System%2C+Expanding+Its+Vascular+Intervention+Portfolio/26518966.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Endologix+Acquires+Pounce%E2%84%A2+Thrombectomy+System%2C+Expanding+Its+Vascular+Intervention+Portfolio/26518966.html for the full story. http://www.streetinsider.com/Press+Releases/Endologix+Acquires+Pounce%E2%84%A2+Thrombectomy+System%2C+Expanding+Its+Vascular+Intervention+Portfolio/26518966.html Tue, 19 May 2026 10:00:00 -0400 A.04232622 A.15494582 A.33357082 O.00059048 O.00674125 O.14910686